English, Middle English
Board Certification / Licensure:
Academics & Trainings
University Of Medicine And Dentistry Of Nj
Awards & Publications
ADDITIONAL PROFESSIONAL TRAINING CyberKnife Full Body Radiosurgery Training course Accuray Training Center Sunnyvale, CA 2012 Principles and Practice of Gamma Knife Radiosurgery / emphasis on Perfexion course University of Pittsburgh Center for Image Guided Neuosurgery Pittsburgh, PA 2011 Leksell Gamma Plan Advanced Training course Elekta Training Center Norcross, GA 2006 Principles and Practice of Gamma Knife Radiosurgery course University of Pittsburgh Center for Image Guided Neurosurgery Pittsburgh, PA 2004 Stereotactic guided precision radiotherapy using stereotactic body frame course Karolinska Institute Stockholm, Sweden 2002 AWARDS / GRANTS Co-Investigator Highly Sensitive Raman Gas Spectroscopy of Exhaled Breath for Non-Invasive Detection of Lung Cancer ECU Division of Research, Economic Development and Engagement 2016 Principal Investigator C. Coach Rock Roggerman Cancer Research Fund Investigating the potential of Civa Sheet Brachytherapy device in resectable pancreas cancer 2014 Burroughs Wellcome Osteopathic Research Fellowship 1985 The C. Kent Warner Award Department of Biology William Paterson College of New Jersey 1980 CLINTON H. LEINWEBER D.O. Page 3 of 3 clinton h leinweber do 050120.docx Who’s Who Among Students in American Universities and Colleges William Paterson College of New Jersey 1979-1980 RECENT PUBLICATIONS Articles Ferreira C, Johnson D, Rasmussen K, Leinweber C, Salahuddin A, Jung JW A novel conformal superficial high-dose rate brachytherapy device for treatment of non-melanoma skin cancer and keloids. Brachytherapy 2017 16:1 215-222. Harris KB, Corbett MR, Mascarenhas H, Lee KS, Hyder A, Leinweber C, Ju AW Single institution analysis of 126 patients treated with stereotactic radiosurgery for brain metastasis. Frontiers in Oncology - 2017 Vol. 7 1-6 Abstracts Pinnamaneni R, Hedge AM, Cherukuri DS, Arastu HH, Bowling M, Leinweber C, Stroud CG, Cherry C, Walker PR Sequence of stereotactic ablative radiotherapy and immune checkpoint blockade in the treatment of metastatic lung cancer. J.Clin.Oncol. 2017 35 no.15 suppl. e20665 Barnes T, Harris EE, Hollowman M, Arastu HH, Leinweber C, Ju A, Naves J A quality verification tool to assure complete pre-treatment electronic medical records for patients undergoing radiation therapy. J.Clin.Oncol. 2017 35 no. 8 suppl. 103 Harris EE, Arastu HH, Leinweber C, Ju A, McLaurin R, Blackburn R, Shelton C, Barnes T, Holloman M Adoption of regional peer review program for radiation oncology. J.Clin.Oncol. 2017 35 no. 8 suppl. 67 Grinchak TA, Sokolovic C, Hollan B, Parent T, Cherukuri S, Bowling M, Arastu H, Leinweber C, Walker, P , Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int.J.Radiat.Oncol.Biol.Phys. 2016 Vol 96 suppl. 3491 Hildebrand, JR, Cherukuri S, Arastu HH, Leinweber C, Stroud CG, Parent T, Cherry C, Hardin J, Walker P Outcomes in patients with stage III non-small cell lung cancer treated with cis-platin and irinotecan with concurrent radiotherapy: A multi-disciplinary thoracic oncology experience at East Carolina University. J.Clin.Oncol. 2016 34 no. 5 suppl. e20019 Walker P, Rosenman J, Arastu H, Leinweber C, Aljumail R, Biswas T, Russo S, Parent T, Eubanks S Oligomestatic Non-Small Cell Lung Cancer Treated With Curative Intent - Int.J.Radiat.Oncol.Biol.Phys. 2016 Vol 96 suppl. 200 Cherukuri S, Walker P, Parent T, Ben-Or S, Moran J, Williams R, Arastu HH, Leinweber C ERCC-1 high stage IIb/III esophageal cancer treated with non-platinum based neoadjuvant or definitive chemoradiotherapy. J.Clin.Oncol. 2014 32 no. 15 suppl. e15047 Laack N, Galanis E, Leinweber C, Buckner J, Giannini C, Geoffroy FJ, Jaeckle GA, Sarkaria JN Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed Glioblastoma multiforme. J.Clin.Oncol. 2012 30 no.15 suppl. 2032
The terms and conditions (hereinafter collectively referred to as, the "Terms of Service") set out herein shall be a legally binding Agreement between Orane Healthcare India Pvt. Ltd., a company incorporated under the Companies Act, 1956, having its registered office at No.174, Rangasamy Goundenpudur, Chinniyampalayam (PO), Coimbatore – 641062, Tamil Nadu, India (hereinafter interchangeably referred to as, "We" or "Us" or "Our" or the "Company" or "iCliniq"), and you (hereinafter referred to as, "You" or "Your"), as the Registered Doctor (defined below) or Registered Alternative Medicine Practitioner (defined below) or Wellness Professional (defined below) or User / Registered User (defined below) on the Platform (defined below) and/or the services offered through the Platform. The Platform is developed and maintained by the Company.
The Terms of Service shall govern your use of the Platform and its services offered through the Platform, therefore, please read and understand the Terms of Service before you access the services, view, download, install or Register with or use the Platform. If you are not agreeable to this Terms of Service, then you shall not access, view, download or install the Platform, or use the Platform or the services offered through the Platform, and if you are accessing, installing, using, or viewing the Platform, then you shall delete the account and desist from such accessing, using, installing or viewing the Platform.
PART – A
PART - B
PART - C
*Please check to continue futher